Improvement of Lumbar Bone Mass after Infliximab Therapy in Crohn’s Disease Patients
oleh: Marina Mauro, Vladimir Radovic, David Armstrong
| Format: | Article |
|---|---|
| Diterbitkan: | Wiley 2007-01-01 |
Deskripsi
BACKGROUND: Patients with Crohn’s disease (CD) have a high risk of developing osteoporosis, but the mechanisms underlying bone mass loss are unclear. Elevated proinflammatory cytokines, such as tumour necrosis factor-alpha (TNFα), have been implicated in the pathogenesis of bone resorption.